Coronary heart disease

Treatment of coronary artery disease

The CAPE study has shown that amlodipine added to the basic treatment of patients with angina, anginal attacks and prevents myocardial ischemia for 24 hours in the international double-blind, placebo-controlled CAPE II study, which lasted 8 weeks, Included 315 patients stable angina and amlodipine (Norvasc ®) at a dose of 5-10 mg /day or placebo. 65% of patients in this study prior to the administration of amlodipine (Norvasc ®) already were given b-blockers…